Skip to content
Open access

Causal association and shared mechanisms between Graves' disease and prostate cancer: insights from Mendelian randomization, machine learning, and comprehensive bioinformatics.

Jul 2026 · The Aging Male · Vol 29 1, pp. 2695558 · 0 citations · 45 references
Medicine

TL;DR

This study provided novel insights into the protective effect of GD against PCa and identified shared genes and immune mechanisms, offering a deeper understanding of the common mechanisms between GD and PCa.

Abstract

Background

Observational studies link hyperthyroidism to increased prostate cancer (PCa) risk, but causality and mechanisms remain unclear. Graves' disease (GD), the primary cause of hyperthyroidism, involves chronic immune dysregulation that may influence PCa through shared immune pathways.

Methods

We performed bidirectional two-sample Mendelian randomization (MR) using IEU Open GWAS data, then integrated differential expression analysis, weighted gene co-expression network analysis (WGCNA), and machine learning on Gene Expression Omnibus (GEO) datasets to identify shared gene, validated by ROC curves, and analyzed immune profilesusing ssGSEA.

Results

MR analysis indicated that genetic predisposition to GD significantly reduced PCa risk (OR = 0.997, 95% CI = 0.996-0.999, p = 0.004), with consistentsensitivity and no reverse causality. Four key genes (BTG2, JUN, JUNB, FOS) were identified as robust shared genes with high predictive accuracy in external validation. Immune profiles analysis revealed disease-specific associations of these genes: BTG2 and JUNB correlated with memory CD8 T cells in GD, whereas all four genes correlated with dendritic cells, mast cells and NK cells in PCa.

Conclusion

This study provided novel insights into the protective effect of GD against PCa and identified shared genes and immune mechanisms, offering a deeper understanding of the common mechanisms between GD and PCa.

Read PDF

Similar papers

Jul 2026

Causal relationship and pathogenic mechanism analysis of breast cancer and coronary heart disease based on mendelian randomization and transcriptome data analysis

The genetic causal relationship between BC and CHD in Asian populations is established for the first time, and the inflammation-immune-metabolism molecular axis mediating comorbidities is revealed, revealing the inflammation-immune-metabolism molecular axis mediating comorbidities.

Mingbin Xie, Yuanhong Wu, Xinyao Jin et al. · 0 citations
Open access Jul 2026

Integrating Mendelian randomization, machine learning and retrospective clinical data: an exploratory analysis of the cross-disease association between CHB and PD, with a focus on eosinophil alterations

Genetic susceptibility to chronic hepatitis B is inversely associated with Parkinson’s disease risk, and MAP4K3, RTN3, phenylalanine metabolism, and eosinophil represent candidate therapeutic targets and peripheral biomarkers for PD risk reduction.

Yao Ge, Hongbin Cai, Yi-Ke Li et al. · 0 citations
Open access Jul 2026

Modifiable risk factors and skin cancers: a multi-omics Mendelian randomization study from causal inference to drug target discovery

AK appears to increase the risk of melanoma, whereas alcohol consumption may be protective against SCC, and EDEM2 may represent a potential therapeutic target for melanoma, while MAPK3, NRBP1, ANKK1, IL27, and ADH5 are promising candidate targets for SCC.

Zhen Qin, Wuda Huoshen, Xueqing Li et al. · 0 citations
Open access Aug 2026

Potential Shared Immunometabolic Signatures Between Familial Hypercholesterolemia and Major Depressive Disorder: Integrative Transcriptomic Analysis, Mendelian Randomization, and Clinical Validation

It is suggested that CD4 may represent a promising immune-related candidate signature associated with the co-occurrence of FH and MDD, warranting further functional validation.

Chen-Xi Liu, Yu-Ting Li, Xiang Cao et al. · 0 citations
Open access Aug 2026

Integrated Mendelian Randomization and Single-Cell Transcriptomics Reveal T Cell Immune Mechanisms in Systemic Lupus Erythematosus–Bladder Cancer Comorbidity

This study provides preliminary evidence suggestive of autoimmune–malignancy comorbidity mechanisms and proposed candidate genes in SLE–bladder cancer comorbidity, potentially involved in immune dysregulation through T cell terminal differentiation modulation, are proposed as hypothesis-generating exploratory candidate...

Desheng Zhang, Huan Ren, Yunjin Bai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.